• Skip to main content
Inovia
  • Portfolio
    • Active companies
    • Exited companies
    • Emerging Managers
  • Founders
    • Company Founders
    • Emerging
      Manager
      Partners
  • About Inovia
    • Team
    • Advisors
    • ESG
    • Gen AI
  • Inovia Conversations
  • Careers
Color scheme
Font size
Animations
Inovia
  • Investor Portal
  • Press Room
  • Portfolio
    • Active companies
    • Exited companies
    • Emerging Managers
  • Founders
    • Company Founders
    • Emerging
      Manager
      Partners
  • About Inovia
    • Team
    • Advisors
    • ESG
    • Gen AI
  • Inovia Conversations
  • Careers
  • Investor portal
  • Press Room
  • Active companies
  • Founders
  • About Inovia
  • Insights
  • Portfolio Jobs
X LinkedIn

Press room company: BenchSci

press-room

Founders Journey ft. Liran Belenzon of BenchSci

View press-room

press-room

Inovia Portfolio Shines in Deloitte’s 2024 Technology Fast 50: Neo Financial, Hopper, Fellow, BenchSci, Certn, and Lightspeed Recognized for Outstanding Growth

View press-room

press-room

BenchSci: Building the Disease Biology Generative AI Platform for Pharma R&D

View press-room

press-room

Inovia Charts a Course for VC in the Generative AI Age

View press-room

press-room

Canada Helped Lay the Foundations for Today’s AI Boom. Can It Reap the Rewards?

View press-room

press-room

BenchSci, Inovia, Ada Among #CDNTech Orgs Pledging to Fight Workplace Hate in Wake of Israel-Hamas War

View press-room

press-room

Al Gore-led Fund Leads CAD$95M Investment in Toronto’s BenchSci, Which Uses AI to Hasten Drug Discovery

View press-room

press-room

AI Drug Discovery Startup BenchSci Scores $63 Million Series C Round Led by Inovia, TCV

View press-room

Inovia

© 2025 Inovia. All rights reserved.

  • Privacy Policy
  • Anti-Harassment Policy
  • Manage cookies
  • Active companies
  • Founders
  • About Inovia
  • Insights
  • Portfolio Jobs
X LinkedIn

Stay in touch

Subscribe to our newsletter

"*" indicates required fields